Product
Autologous Hematopoietic Stem Cell Transplantation
1 clinical trial
1 indication
Indication
Refractory Systemic Lupus ErythematosusClinical trial
Remission Induction Therapy for Refractory Systemic Lupus Erythematosus With Autologous Hematopoietic Stem Cell Transplantation (AHSCT) Versus Rituximab (antiCD20) Followed by Maintenance Therapy With Mycophenolate Mofetil (MMF)Status: Withdrawn, Estimated PCD: 2013-07-01